Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial

BACKGROUND: Pollen extracts and chemically modified allergoids are used successfully in allergen immunotherapy (AIT). Recombinant extracts offer potential advantages with respect to pharmaceutical quality, standardization and dosing. A hypoallergenic recombinant folding variant of the major birch po...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimek, Ludger, Bachert, Claus, Lukat, Karl-Friedrich, Pfaar, Oliver, Meyer, Hanns, Narkus, Annemie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553934/
https://www.ncbi.nlm.nih.gov/pubmed/26328056
http://dx.doi.org/10.1186/s13601-015-0071-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553934/
https://www.ncbi.nlm.nih.gov/pubmed/26328056
http://dx.doi.org/10.1186/s13601-015-0071-x

Ejemplares similares